Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Botond Csiky

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Orvosi Hetilap|March 31, 2004
[Hypertension and 24-hours blood pressure monitoring in kidney diseases]Botond Csiky, István Wittmann, Judit Nagy
Biomedicines|March 28, 2025
Prognostic Significance of Visit-to-Visit Ultrafiltration Volume Variability in Hemodialysis PatientsBalázs Sági, Tibor Vas, Éva Fejes, et al.
Journal of Clinical Medicine|October 29, 2025
The Significance of Palliative Care in Managing Pain for Patients Undergoing HemodialysisNóra Szigeti, Botond Csiky, Ágnes Csikós, et al.
International Urology and Nephrology|June 12, 2012
Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patientsBotond Csiky, Judit Bene, Istvan Wittmann, et al.
Renal Failure|March 16, 2012
Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patientsJudit Bene, Botond Csiky, Istvan Wittmann, et al.
Blood Purification|August 5, 2021
Cardiometabolic Effects of Irisin in Patients with End-Stage Renal Disease on Regular Hemo- or Peritoneal DialysisBotond Csiky, Balázs Sági, Vanessza Emmert, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|March 4, 2011
Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysisJudit Bene, Botond Csiky, Katalin Komlosi, et al.
Biomedicines|June 27, 2024
Does Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?Balázs Sági, Tibor Vas, Botond Csiky, et al.
Journal of Clinical Medicine|February 24, 2024
Are Platelet-Related Parameters Prognostic Predictors of Renal and Cardiovascular Outcomes in IgA Nephropathy?Balázs Sági, Tibor Vas, Botond Csiky, et al.
Journal of Clinical Medicine|October 16, 2024
Association between Visit-to-Visit Ultrafiltration Volume Variability, Vascular Biomarkers and Cardiovascular Parameters in Chronic Hemodialysis PatientsBalázs Sági, Tibor Vas, Rita Klaudia Jakabfi-Csepregi, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Orvosi Hetilap|March 31, 2004
[Hypertension and 24-hours blood pressure monitoring in kidney diseases]Botond Csiky, István Wittmann, Judit Nagy
Biomedicines|March 28, 2025
Prognostic Significance of Visit-to-Visit Ultrafiltration Volume Variability in Hemodialysis PatientsBalázs Sági, Tibor Vas, Éva Fejes, et al.
Journal of Clinical Medicine|October 29, 2025
The Significance of Palliative Care in Managing Pain for Patients Undergoing HemodialysisNóra Szigeti, Botond Csiky, Ágnes Csikós, et al.
International Urology and Nephrology|June 12, 2012
Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patientsBotond Csiky, Judit Bene, Istvan Wittmann, et al.
Renal Failure|March 16, 2012
Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patientsJudit Bene, Botond Csiky, Istvan Wittmann, et al.
Blood Purification|August 5, 2021
Cardiometabolic Effects of Irisin in Patients with End-Stage Renal Disease on Regular Hemo- or Peritoneal DialysisBotond Csiky, Balázs Sági, Vanessza Emmert, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|March 4, 2011
Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysisJudit Bene, Botond Csiky, Katalin Komlosi, et al.
Biomedicines|June 27, 2024
Does Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?Balázs Sági, Tibor Vas, Botond Csiky, et al.
Journal of Clinical Medicine|February 24, 2024
Are Platelet-Related Parameters Prognostic Predictors of Renal and Cardiovascular Outcomes in IgA Nephropathy?Balázs Sági, Tibor Vas, Botond Csiky, et al.
Journal of Clinical Medicine|October 16, 2024
Association between Visit-to-Visit Ultrafiltration Volume Variability, Vascular Biomarkers and Cardiovascular Parameters in Chronic Hemodialysis PatientsBalázs Sági, Tibor Vas, Rita Klaudia Jakabfi-Csepregi, et al.
Pageof 4